Contrasting Profound Medical (PROF) and The Competition

Profound Medical (NASDAQ: PROF) is one of 178 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its rivals? We will compare Profound Medical to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, earnings, risk and institutional ownership.

Profitability

This table compares Profound Medical and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Profound Medical -345.14% -41.52% -34.09%
Profound Medical Competitors -700.83% -1,285.29% -23.20%

Analyst Ratings

This is a summary of current ratings for Profound Medical and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Profound Medical 0 0 0 0 N/A
Profound Medical Competitors 1363 4333 7068 406 2.49

As a group, “Surgical & medical instruments” companies have a potential upside of 9.22%. Given Profound Medical’s rivals higher possible upside, analysts clearly believe Profound Medical has less favorable growth aspects than its rivals.

Institutional and Insider Ownership

24.1% of Profound Medical shares are held by institutional investors. Comparatively, 40.4% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 16.5% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Profound Medical and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Profound Medical $4.17 million -$15.22 million -13.56
Profound Medical Competitors $1.16 billion $112.57 million -11.59

Profound Medical’s rivals have higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Profound Medical rivals beat Profound Medical on 7 of the 9 factors compared.

About Profound Medical

Profound Medical Corp. operates as a medical technology company develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.